Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 4/20 | 0.48 |
| ▸ | MAPT | P10636 | 10/20 | 0.47 |
| ▸ | NPC1 | O15118 | 3/20 | 0.47 |
| ▸ | RAB9A | P51151 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | ABCB1 | P08183 | 4/20 | 0.47 |
| ▸ | ABCC1 | P33527 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.44 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | ABCG2 | Q9UNQ0 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.44 |
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | GAA | P10253 | 1/20 | 0.42 |
| ▸ | CRHBP | P24387 | 1/20 | 0.42 |
| ▸ | CRHR2 | Q13324 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5064094 | 0.84 | HDAC2 (0.59) | LMNAMAPTALDH1A1KDM4EHPGD | |
| SCHEMBL1067097 | 0.78 | MAPT (0.49) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1066697 | 0.78 | ABCB1 (0.60) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4581161 | 0.76 | ABCB1 (0.57) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL8293254 | 0.74 | MAPT (0.59) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1067526 | 0.74 | MAPT (0.49) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4579515 | 0.74 | ABCB1 (0.55) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4580292 | 0.74 | MAPT (0.48) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL4580126 | 0.72 | MAPT (0.48) | LMNAMAPTNPC1RAB9ASMN1; SMN2 | |
| SCHEMBL1068485 | 0.72 | ADORA3 (0.59) | LMNAMAPTNPC1RAB9ASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080132459-A1 | Inhibitors of Histone Deacetylase | METHYLGENE, INC. (CA) | 2008-06-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080132459-A1 | Inhibitors of Histone Deacetylase | HDAC1, HDAC5, HDAC3 | LMNA 1922/4885MAPT 2110/4885NPC1 1197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.